Search
for
Sort by
Research 91–120 of 1000+
- Janus Kinase inhibitors in dermatology: a review
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- JAK inhibitors and alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- A review of Janus kinase inhibitor use in scarring alopecia
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- JAK Inhibitors for Treatment of Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Janus kinase inhibitors for alopecia areata: A narrative review